Linked from

The 12 pages that link to Drug design, each with the reason it gives.

• Molecular geometryRelated: Drug molecules must adopt shapes and orientations compatible with their target binding sites.

• Protein structureRelated: Protein structures can expose binding pockets used to guide structure-based drug design.

• Quantum chemistryRelated: Quantum calculations can characterize binding interactions and reactive molecular features.

• Computational chemistryRelated: Molecular calculations can estimate binding, properties, and candidate structures.

• Active siteRelated: Active-site shape and chemistry guide the design of enzyme-targeting drugs.

• TautomerismRelated: A drug's tautomer distribution can change its binding geometry and interactions.

• ConformationRelated: Drug binding depends on the shapes available to both ligand and target.

• Molecular structureRelated: Molecular shape and chemical features guide how candidate drugs bind targets.

• Steric effectsRelated: Drug designers tune molecular bulk to improve target fit, selectivity, and metabolic stability.

• Arieh WarshelRelated: Modeling molecular interactions and energetics can inform the design of enzyme-targeting drugs.

• Derek BartonRelated: Understanding three-dimensional molecular shape remains relevant to designing biologically active compounds.

• Atomic and molecular structureRelated: Precise molecular structures enable predictions of target binding and chemical behavior.